Micromet, Inc. (MITI)

Micromet, Inc. is related to 3 other symbols. To date we've encountered 9 releases involving Micromet, Inc..

Last Price: 4.02 (+0.03) - 1/9/2009, 3:59pm

• Open: 3.97
• High: 4.07
• Low: 3.94

Micromet, Inc. Options

• Micromet, Inc. "Business Partners"
• Micromet, Inc. Press Releases
• Micromet, Inc. News
• Micromet, Inc. Contact
• Micromet, Inc. Related (via TRYNT)

Micromet, Inc. "Business Partners"

A "business partner" is defined as a third party company that has co-released at least one press release with Micromet, Inc..

• GG
• ICI
• TLN

^

Micromet, Inc. Press Releases

• Micromet Inc.: Micromet, Inc. to Present at Rodman & Renshaw 8th Annual Healthcare Conference (Trackbacks) (Backlinks), Fri, 27 Oct 2006 0:00:00 PDT

  CARLSBAD, CA (MARKET WIRE) Micromet, Inc. (NASDAQ: MITI), a biopharmaceutical company focusing on the development of novel, proprietary antibody-based products for cancer, inflammatory and autoimmune diseases, announced today that Christian Itin, President & Chief Executive Officer of Micromet, Inc. will give a corporate presentation to the investment community at the Rodman & Renshaw 8th

• Micromet Inc.: Micromet Presents New Anti-IL-2 Antibody with Unique Mode of Action (Trackbacks) (Backlinks), Wed, 25 Oct 2006 0:09:00 PDT

  CARLSBAD, CA (MARKET WIRE)

• Micromet Inc.: Micromet, Inc. Expands Management and Appoints Christopher P. Schnittker as Senior Vice President and Chief Financial Officer (Trackbacks) (Backlinks), Thu, 12 Oct 2006 0:08:00 PDT

  CARLSBAD, CA (MARKET WIRE)

• Micromet: Final Data from Two Phase II Trials Indicate Activity of Adecatumumab (MT201) in Breast and Prostate Cancer (Trackbacks) (Backlinks), Mon, 2 Oct 2006 0:07:00 PDT

  CARLSBAD, CA and GENEVA, SWITZERLAND (MARKET WIRE) Micromet, Inc. (NASDAQ: MITI), a biopharmaceutical company focusing on the development of novel, proprietary antibody-based products for cancer, inflammatory and autoimmune diseases, and Serono (virt-x: SEO and NYSE: SRA) today reported on the outcome of two phase II trials testing the activity of adecatumumab (MT201) in metastatic breast cancer and in prostate cancer, respectively.

• Micromet Inc.: Micromet, Inc. to Present at UBS Global Life Sciences Conference 2006 (Trackbacks) (Backlinks), Wed, 13 Sep 2006 23:10:00 PDT

  CARLSBAD, CA (MARKET WIRE)

• Micromet Inc.: Micromet Secures $25 Million Committed Equity Financing Facility (Trackbacks) (Backlinks), Thu, 31 Aug 2006 0:15:00 PDT

  CARLSBAD, CA (MARKET WIRE) Micromet, Inc. (NASDAQ: MITI), a biopharmaceutical company focusing on the development of novel, proprietary antibody-based products for cancer, inflammatory and autoimmune diseases, today announced that it has entered into a Committed Equity Financing Facility (CEFF) with Kingsbridge Capital Limited, a private investment group. Under the terms of the agreement, Kingsbridge has committed to provide up to $25 million of

• Micromet Inc.: Study Supports Potential of Micromet's Human Antibody MT203 As Novel Anti-Inflammatory Treatment (Trackbacks) (Backlinks), Wed, 14 Jun 2006 23:57:00 PDT

  MÜNCHEN, GERMANY (MARKET WIRE)

• Micromet Inc.: Micromet, Inc. to Present at Pacific Growth Equities Life Sciences Growth Conference 2006 (Trackbacks) (Backlinks), Wed, 7 Jun 2006 2:14:00 PDT

  MÜNCHEN, GERMANY (MARKET WIRE)

• Micromet AG: Micromet, Inc. Reports CancerVax's First Quarter 2006 Financial Results (Trackbacks) (Backlinks), Wed, 10 May 2006 3:37:00 PDT

  MÜNCHEN, GERMANY (MARKET WIRE)

^

Micromet, Inc. News

• Micromet Key Events for 2009 (PR Newswire), Mon, 5 Jan 2009 12:00:00 Etc/GMT
• Micromet Presents Updated Data on the Phase 1 Trial Studying Blinatumomab (MT103/MEDI-538) in Patients with Advanced Non-Hodgkin's Lymphoma (PR Newswire), Tue, 9 Dec 2008 12:00:00 Etc/GMT
• Data Presented at ASH Annual Meeting Indicates the Potential of T-Cell Engaging BiTE Antibody Blinatumomab as a Consolidation Treatment for Aggressive Leukemias (PR Newswire), Mon, 8 Dec 2008 12:00:00 Etc/GMT
• Micromet to Present at the RBC Capital Markets Healthcare Conference (PR Newswire), Fri, 5 Dec 2008 21:15:00 Etc/GMT
• Micromet, Inc. to Host Webcast and Conference Call to Discuss Blinatumomab Data Presented at American Society of Hematology Annual Meeting (PR Newswire), Wed, 3 Dec 2008 12:00:00 Etc/GMT
• MICROMET, INC. Files SEC form 8-K, Entry into a Material Definitive Agreement, Unregistered Sale of Equity Securities (EDGAR Online), Tue, 2 Dec 2008 12:06:07 Etc/GMT
• Micromet Expands Committed Equity Financing Facility to $75 Million (PR Newswire), Tue, 2 Dec 2008 12:00:00 Etc/GMT
• Micromet Added to NASDAQ Biotechnology Index (PR Newswire), Wed, 26 Nov 2008 19:28:00 Etc/GMT
• Micromet to Present at the Piper Jaffray 20th Annual Health Care Conference (PR Newswire), Wed, 26 Nov 2008 19:00:00 Etc/GMT
• MICROMET, INC. Files SEC form 8-K, Change in Directors or Principal Officers (EDGAR Online), Wed, 19 Nov 2008 21:03:27 Etc/GMT
• Semi-Annual Changes to the NASDAQ Biotechnology Index (GlobeNewswire), Sat, 15 Nov 2008 01:02:00 Etc/GMT
• MICROMET, INC. Financials (EDGAR Online Financials), Thu, 13 Nov 2008 14:04:43 Etc/GMT
• Micromet to Present Interim Data from Two Studies for T Cell Engaging BiTE Antibody Blinatumomab at American Society of Hematology Annual Meeting (PR Newswire), Thu, 13 Nov 2008 12:00:00 Etc/GMT
• New Star Analyst Rankings for MICROMET INC (StarMine), Sun, 9 Nov 2008 14:19:42 Etc/GMT
• Micromet Inc. Earnings Call scheduled for 9:00 am ET today (CCBN), Thu, 6 Nov 2008 14:00:00 Etc/GMT
• Q3 2008 Micromet Inc. Earnings Release - Before Market Open (CCBN), Thu, 6 Nov 2008 12:07:04 Etc/GMT
• MICROMET, INC. Files SEC form 8-K, Results of Operations and Financial Condition, Financial Statements and Exhibits (EDGAR Online), Thu, 6 Nov 2008 12:06:56 Etc/GMT
• Micromet, Inc. Reports Third Quarter 2008 Financial Results (PR Newswire), Thu, 6 Nov 2008 12:00:00 Etc/GMT
• Micromet Presents Data at the 23rd Annual Meeting of the International Society for Biological Therapy of Cancer on the Activity of Human Antibody Adecatumumab against KRAS-mutated Colon Cancer Cells (PR Newswire), Tue, 4 Nov 2008 12:00:00 Etc/GMT
• Micromet, Inc. to Host Conference Call and Webcast to Discuss Third Quarter 2008 Financial Results (PR Newswire), Wed, 22 Oct 2008 14:00:00 Etc/GMT

^

Micromet, Inc. Contact

TRYNT Related

• Mitra Investindo Tbk (MITI.JK)

^

What is a Stock Cloud?

A Stock Cloud is a tag cloud like display of stock ticker symbols. The larger the ticker symbol the more frequent that company distributes press releases.